Exploring the effectiveness of persuasive games for disease prevention and awareness and the impact of tailoring to the stages of change

被引:10
|
作者
Mulchandani, Dinesh [1 ]
Alslaity, Alaa [1 ]
Orji, Rita [1 ]
机构
[1] Dalhousie Univ, Fac Comp Sci, Halifax, NS, Canada
来源
HUMAN-COMPUTER INTERACTION | 2023年 / 38卷 / 5-6期
基金
加拿大自然科学与工程研究理事会;
关键词
Persuasive games; persuasive strategies; behavior change; behavior change systems; stages of change; motivation; tailoring; personalization; gamification; COVID; covid-19; health; Games; TRANSTHEORETICAL MODEL; BEHAVIOR-CHANGE; ARCS MODEL; DESIGN; PROMOTE; STRESS;
D O I
10.1080/07370024.2022.2057858
中图分类号
TP3 [计算技术、计算机技术];
学科分类号
0812 ;
摘要
Persuasive games are widely implemented in the healthcare domain to promote behaviour change among individuals. Previous research shows that using persuasive games increases motivation and awareness, leading to a positive change in behaviour. However, there is little knowledge on which persuasive strategies will motivate people at different Stages of Behaviour Change and whether tailoring persuasive games to match users’ stages of change will increase their effectiveness with respect to their motivational appeal towards promoting disease awareness and prevention using the ARCS motivation scales and their intention to adopt the precautionary measures. To address this gap, using COVID-19 as a case study, we designed two different versions of a persuasive game, called COVID Pacman, using different persuasive strategies. The two versions of the game target the same goal of motivating the adoption of precautionary measures. We conducted a quantitative study (N=127) followed by semi-structured interviews of 18 participants. The results of conducting an ANOVA on the quantitative data and thematic analysis on the qualitative study show that tailoring the persuasive games to individual’s stages of change by using appropriate persuasive strategies increased their effectiveness with respect to their ability to motivate people to adopt the precautionary measures towards disease prevention compared to the non-tailored version. © 2022 Taylor & Francis Group, LLC.
引用
收藏
页码:459 / 494
页数:36
相关论文
共 36 条
  • [21] Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and Stroke
    Heller, David J.
    Coxson, Pamela G.
    Penko, Joanne
    Pletcher, Mark J.
    Goldman, Lee
    Odden, Michelle C.
    Kazi, Dhruv S.
    Bibbins-Domingo, Kirsten
    CIRCULATION, 2017, 136 (12) : 1087 - +
  • [22] Effectiveness of awareness raising interventions on knowledge about Rheumatic Heart Disease and change in care seeking behavior for throat infection in Lalitpur, Nepal
    Regmi, Prakash Raj
    Sanjel, Keshab
    NEPALESE HEART JOURNAL, 2019, 16 (01) : 15 - 18
  • [23] EXPLORING THE RELATIONSHIP BETWEEN CHURCH ENVIRONMENT AND CHANGE IN DIETARY HABITS AFTER A FAITH-BASED CARDIOVASCULAR DISEASE PREVENTION PROGRAM
    Tucker, Shanna A.
    Soroka, Orysya
    Amanquah, Priscilla
    Ramos, Rosio
    Tettey, Naa-solo
    Andersen, Holly S.
    Phillips, Erica
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S126 - S126
  • [24] Zoonotic infections in Alaska: disease prevalence, potential impact of climate change and recommended actions for earlier disease detection, research, prevention and control
    Hueffer, Karsten
    Parkinson, Alan J.
    Gerlach, Robert
    Berner, James
    INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH, 2013, 72
  • [25] Daily almond consumption in cardiovascular disease prevention via LDL-C change in the US population: a cost-effectiveness analysis
    Wang Jifan
    Lee Bravatti, Michelle A.
    Johnson, Elizabeth J.
    Raman, Gowri
    BMC PUBLIC HEALTH, 2020, 20 (01)
  • [26] COST-EFFECTIVENESS ANALYSIS AND BUDGET IMPACT MODEL OF LP(A) TESTING IN PORTUGUESE PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE FOR SECONDARY PREVENTION
    Monge, S.
    Ferreira, C.
    Gomes-da-Costa, J.
    VALUE IN HEALTH, 2024, 27 (12)
  • [27] Implementation-effectiveness trial of systematic family health history based risk assessment and impact on clinical disease prevention and surveillance activities
    Wu, R. Ryanne
    Myers, Rachel A.
    Neuner, Joan
    McCarty, Catherine
    Haller, Irina, V
    Harry, Melissa
    Fulda, Kimberly G.
    Dimmock, David
    Rakhra-Burris, Tejinder
    Buchanan, Adam
    Ginsburg, Geoffrey S.
    Orlando, Lori A.
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [28] Impact of China's Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease
    Wang, Miao
    Liu, Jing
    Bellows, Brandon K.
    Qi, Yue
    Sun, Jiayi
    Liu, Jun
    Moran, Andrew E.
    Zhao, Dong
    GLOBAL HEART, 2020, 15 (01)
  • [29] Implementation-effectiveness trial of systematic family health history based risk assessment and impact on clinical disease prevention and surveillance activities
    R. Ryanne Wu
    Rachel A. Myers
    Joan Neuner
    Catherine McCarty
    Irina V. Haller
    Melissa Harry
    Kimberly G. Fulda
    David Dimmock
    Tejinder Rakhra-Burris
    Adam Buchanan
    Geoffrey S. Ginsburg
    Lori A. Orlando
    BMC Health Services Research, 22
  • [30] Evaluation of Chronic Disease Prevention and Control Public Service Advertisement on the Awareness and Attitude Change among Urban Population in Chongqing, China: A Cross-Sectional Study
    Wu, Tingting
    Hu, Ping
    Huang, Hao
    Wu, Chengbin
    Fu, Zhirong
    Du, Lei
    Xu, Xianglong
    Shi, Zumin
    Zhao, Yong
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2017, 14 (12):